Skip to main content
25 January 2021
Last updated:
Monday 25 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Mario Philips becomes CEO of Polyplus-transfection

Monday 9 November 2020
Company
Polyplus-transfection SA
Appointee Name
Mario 
Philips
Country

France

France-based Polyplus-transfection SA has appointed Mario Philips as chief executive officer to lead its service business for the gene and cell therapy industry. Mr Philips has more than 20 years of experience in the life science and bioprocessing sectors, and was previously CEO of Polyneuros SAS, a developer of kits for the diagnosis and treatment of neurodegenerative conditions. He graduated from Groep T – Internationale Hogeschool Leuven with a degree in marketing, after earning a degree in biochemistry engineering from Hogeschool Gent. Mr Philips succeeds Karsten Wilking, who will become a strategic advisor to the company.
Polyplus-transfection announced the appointment on 3 November 2020.

Copyright 2020 Evernow Publishing Ltd

 

 

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

T-knife appoints Thomas Soloway as chief executive
Thursday January 21 2021
Domainex makes two executive appointments
Thursday January 21 2021
Richard Francis named CEO of Purespring
Tuesday January 19 2021
Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.